Bio-Rad Laboratories Inc
(NYSE:BIO.B)
$
283.4504
0 (0%)
Market Cap: 8.14 Bil
Enterprise Value: 7.97 Bil
PE Ratio: 0
PB Ratio: 0.90
GF Score: 77/100 - Q1 2024 Bio Rad Laboratories Inc Earnings Call TranscriptMay 07, 2024$279.91Earnings
- Bio Rad Laboratories Inc at Citigroup Inc Unplugged Medtech and Life Sciences Access Day TranscriptFeb 29, 2024
- Q4 2023 Bio Rad Laboratories Inc Earnings Call TranscriptFeb 15, 2024$328.45 (+2.31%)Earnings
- Q3 2023 Bio Rad Laboratories Inc Earnings Call TranscriptOct 26, 2023$301Earnings
- Bio Rad Laboratories Inc at Wells Fargo Healthcare Conference TranscriptSep 07, 2023
- Q2 2023 Bio Rad Laboratories Inc Earnings Call TranscriptAug 03, 2023$387.55Earnings
- Bio Rad Laboratories Inc at Jefferies Healthcare Conference TranscriptJun 08, 2023
- Bio Rad Laboratories Inc at RBC Capital Markets Global Healthcare Conference TranscriptMay 17, 2023
- Q1 2023 Bio Rad Laboratories Inc Earnings Call TranscriptMay 04, 2023$467.95 (+0.83%)Earnings
- Bio Rad Laboratories Inc at Citi Healthcare & Medtech Conference TranscriptMar 02, 2023
- Q4 2022 Bio Rad Laboratories Inc Earnings Call TranscriptFeb 16, 2023$404.66Earnings
- Bio Rad Laboratories Inc at JPMorgan Healthcare Conference TranscriptJan 11, 2023
- Bio Rad Laboratories Inc at Credit Suisse Healthcare Conference TranscriptNov 08, 2022
- Q3 2022 Bio Rad Laboratories Inc Earnings Call TranscriptOct 27, 2022$390.84 (+1.79%)Earnings
- Q2 2022 Bio Rad Laboratories Inc Earnings Call TranscriptJul 28, 2022$484.36Earnings
- Q1 2022 Bio Rad Laboratories Inc Earnings Call TranscriptApr 28, 2022$507.99Earnings
- Bio Rad Laboratories Inc Annual Shareholders Meeting TranscriptApr 26, 2022
- Bio Rad Laboratories Inc Investor Day TranscriptFeb 25, 2022
- Q4 2021 Bio Rad Laboratories Inc Earnings Call TranscriptFeb 10, 2022$627.34 (-1.70%)Earnings
- Bio Rad Laboratories Inc at JPMorgan Healthcare Conference (Virtual) TranscriptJan 11, 2022
- Q3 2021 Bio Rad Laboratories Inc Earnings Call TranscriptOct 28, 2021$729.86Earnings
- Bio Rad Laboratories Inc at Wells Fargo Virtual Healthcare Conference TranscriptSep 09, 2021
- Q2 2021 Bio Rad Laboratories Inc Earnings Call TranscriptJul 29, 2021$697.76Earnings
- Q1 2021 Bio Rad Laboratories Inc Earnings Call TranscriptApr 29, 2021$631.85 (+5.16%)Earnings
- Bio Rad Laboratories Inc Annual Shareholders Meeting TranscriptApr 27, 2021
- Bio Rad Laboratories Inc at Barclays Global Healthcare Conference (Virtual) TranscriptMar 09, 2021
- Q4 2020 Bio Rad Laboratories Inc Earnings Call TranscriptFeb 11, 2021$635Earnings
- Bio Rad Laboratories Inc at JPMorgan Healthcare Conference (Virtual) TranscriptJan 11, 2021
- Q3 2020 Bio Rad Laboratories Inc Earnings Call TranscriptOct 29, 2020$575.48Earnings
- Q2 2020 Bio Rad Laboratories Inc Earnings Call TranscriptJul 30, 2020$538 (+3.04%)Earnings
- Bio Rad Laboratories Inc to Discuss Purifying Biotherapeutic Molecules with Unique Chromatography Selectivities at BioProcess International Spring Digital Week TranscriptJun 17, 2020
- Q1 2020 Bio Rad Laboratories Inc Earnings Call TranscriptMay 06, 2020$446.53 (+2.54%)Earnings
- Bio Rad Laboratories Inc Annual Shareholders Meeting TranscriptApr 28, 2020
- Q4 2019 Bio Rad Laboratories Inc Earnings Call TranscriptFeb 13, 2020$379.45 (+2.73%)Earnings
- Bio Rad Laboratories Inc at JPMorgan Healthcare Conference TranscriptJan 13, 2020
- Q3 2019 Bio Rad Laboratories Inc Earnings Call TranscriptOct 31, 2019$345.13Earnings
- Q2 2019 Bio Rad Laboratories Inc Earnings Call TranscriptAug 01, 2019$307.28 (-5.16%)Earnings
- Bio Rad Laboratories Inc at Goldman Sachs Global Healthcare Conference TranscriptJun 11, 2019
- Bio Rad Laboratories Inc at Jefferies Healthcare Conference TranscriptJun 04, 2019
- Bio Rad Laboratories Inc at Bank of America Merrill Lynch Health Care Conference TranscriptMay 14, 2019
- Q1 2019 Bio Rad Laboratories Inc Earnings Call TranscriptMay 08, 2019$302Earnings
- Q4 2018 Bio Rad Laboratories Inc Earnings Call TranscriptFeb 28, 2019$272.98Earnings
Bio Rad Laboratories Inc at Goldman Sachs Global Healthcare Conference Transcript
Jun 11, 2019 / 05:40PM GMT
Release Date Price:
$291.07
Patrick B. Donnelly
Goldman Sachs Group Inc., Research Division - Equity Analyst
All right. Great. Thanks for being here. I'm Patrick Donnelly, the tools and diagnostics analyst here at Goldman. Happy to have CEO and CFO of Bio-Rad up here, Norm and Ilan. It's certainly open Q&A, so if anyone has any questions in the audience, feel free to just raise your hands, and I'll call out to you. But Norm, maybe just to start, if you can kind of just talk us through the most recent results and then we can jump into Q&A from there.
Norman D. Schwartz
Bio-Rad Laboratories, Inc. - Chairman, CEO & President
So okay. So I think that you started out pretty well. I think we're pretty pleased with the results. I think that when you look around the world, the markets generally has seemed like they're pretty healthy for us for the year.
Questions & Answers
Patrick B. Donnelly
Goldman Sachs Group Inc., Research Division - Equity Analyst
Okay. And then maybe just on the operational side, obviously, we've seen
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent ![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust_rating.png)
4.6 out of 5
Trustpilot
![](https://static.gurufocus.com/trust.png)